Mumbai-based Aakaar Medical Technologies Ltd is all set to open its Initial Public Offering (IPO) on June 20, 2025, offering shares at a relatively low price, according to an official announcement from the company.
The company, which specializes in cosmetic dermatology and medical aesthetics, will list its shares on the NSE Emerge platform. This IPO consists of a fresh issue of 37.5 lakh equity shares with a face value of Rs 10 each. The price band has been fixed between Rs 68 and Rs 72 per share. At the upper band, the company plans to raise approximately Rs 27 crore from the public.
The share allocation is divided among different investor categories, with 1.88 lakh shares reserved for the Market Maker, 17.79 lakh shares for Qualified Institutional Buyers (QIBs), 5.34 lakh shares for Non-Institutional Investors (HNIs), and 12.48 lakh shares for Retail Investors. The minimum lot size for application is 1,600 shares, which makes it an attractive option even for small investors.
The anchor portion of the IPO opened on June 19, while the public issue will remain open for subscription from June 20 to June 24, 2025. The shares are expected to be listed on June 27, 2025. According to the company, the funds raised will be primarily used to meet working capital requirements and for general corporate purposes.
Indorient Financial Services Limited is the lead manager to the issue, Bigshare Services Private Limited is acting as the registrar, and Alacrity Securities Limited is the designated market maker..